id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0233-0003,FDA,FDA-2008-D-0233,"Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus From Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Cells, Tissues, and Cellular and Tissue-Based Products; Request for Data",Notice,"NRD-Notice of Requesting Data, Info, & Views",2008-07-07T04:00:00Z,2008,7,2008-07-07T04:00:00Z,,2008-07-07T11:57:02Z,E8-15368,0,0,090000648065a4ee
FDA-2008-D-0233-0002,FDA,FDA-2008-D-0233,"Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) - Draft Guidance",Other,GDL-Guidance (Supporting and Related Materials),2008-04-28T04:00:00Z,2008,4,2008-04-28T13:08:29Z,,2024-11-12T04:14:16Z,,1,0,0900006480538137
FDA-2008-D-0233-0001,FDA,FDA-2008-D-0233,"Draft Guidance for Industry: Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion and Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Availability",Notice,NAD-Notice of Availability of Data,2008-04-28T04:00:00Z,2008,4,2008-04-28T04:00:00Z,2008-07-29T03:59:59Z,2024-11-12T04:13:44Z,E8-09253,1,0,0900006480537ea6